V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210037724 | 210007359 | 1.87 | null | Curative (C) | 2018-04-07 | 2018-04-09 | CNS Epen2007 09 Baby Brn vinc+carbo | 1 | N | 210013090 | NOT MATCHED |
| 210037725 | 210007370 | 1.77 | 45.2 | Curative (C) | 2014-08-21 | 2014-08-25 | ALL ALLR3: S/IR: Intens Wk 9-11 | N | null | 210013093 | NOT MATCHED |
| 210037726 | 210007387 | 0 | 30.6 | Curative (C) | null | 2014-12-01 | CNS PNET 5 Medbl L/StRsk Mnt A Carb | 01 | N | 210013117 | NOT MATCHED |
| 210037727 | 210007405 | null | null | Curative (C) | 2018-08-30 | 2019-06-20 | CNS PNET 5 Medbl L/StRsk Mnt A Cis | N | N | 210013144 | NOT MATCHED |
| 210037728 | 210007417 | null | null | Curative (C) | 2014-07-06 | 2014-07-08 | null | 02 | N | 210013173 | NOT MATCHED |
| 210037729 | 210007425 | null | 19.6 | Curative (C) | 2018-02-05 | 2018-03-12 | CNS Medbl HR Maint vinc+ Lomustine | N | N | 210013202 | NOT MATCHED |
| 210037730 | 210007429 | 1.44 | 42.1 | Palliative (P) | 2016-07-19 | 2016-07-25 | ALL UKALL2011 Ind B Sht Dex (Erw) | 02 | N | 210013223 | NOT MATCHED |
| 210037731 | 210007455 | 0 | 8.1 | Curative (C) | 2019-10-20 | 2019-12-01 | CNS Infant MBL HDMTX | 02 | N | 210013286 | NOT MATCHED |
| 210037732 | 210019023 | 0 | 25.6 | Adjuvant (A) | 2017-09-28 | 2017-09-29 | CNS PNET 5 Medbl L/StRsk Mnt B | Y | N | 210013297 | NOT MATCHED |
| 210037733 | 210007468 | null | 12.4 | Curative (C) | 2015-04-03 | 2015-08-14 | CNS Headstart II A Ind 4,5 int | N | N | 210013298 | NOT MATCHED |
| 210037735 | 210033133 | 1.14 | 9.3 | Curative (C) | 2017-12-30 | 2018-09-07 | CNS Medbl Std Risk Maint Carbo | N | N | 210013419 | NOT MATCHED |
| 210037736 | 210007513 | 1.2 | 123.8 | Curative (C) | 2014-08-23 | 2014-08-26 | ALL UKALL2011 Maintenance C4 | N | null | 210013469 | NOT MATCHED |
| 210037737 | 210007521 | null | 21.6 | Curative (C) | 2017-04-20 | 2017-04-21 | ALL ALLR3: S/IR Con Wk6 (PAsp)HDMTx | 02 | N | 210013478 | NOT MATCHED |
| 210037738 | 210007526 | 1.59 | 49.2 | Adjuvant (A) | 2015-11-25 | 2016-02-23 | PCV | 2 | null | 210013481 | PCV |
| 210037739 | 210007546 | 1.7 | null | Adjuvant (A) | 2018-12-09 | 2018-12-09 | PCV | N | null | 210013548 | PCV |
| 210037740 | 210007550 | 1.67 | 45.2 | Disease modification (D) | 2014-05-11 | 2014-08-22 | PCV | N | null | 210013562 | PCV |
| 210037742 | 210007560 | 1.93 | 89 | Palliative (P) | 2016-10-26 | 2016-11-01 | PCV | 02 | N | 210013588 | PCV |
| 210037744 | 210019066 | 1.78 | null | Adjuvant (A) | 2019-05-12 | 2019-05-26 | PCV | N | null | 210013640 | PCV |
| 210037745 | 210007601 | 1.62 | 52 | Palliative (P) | 2015-12-11 | 2015-12-11 | PCV | 02 | N | 210013643 | PCV |
| 210037746 | 210007642 | null | 52.9 | Curative (C) | null | 2018-09-13 | PCV | null | null | 210013724 | PCV |
| 210037747 | 210007648 | 1.67 | 83.6 | Curative (C) | null | 2016-12-04 | Trial Unspecified | Y | Y | 210013727 | TRIAL |
| 210037748 | 210019091 | 1.08 | 68.7 | Curative (C) | 2013-12-06 | 2013-12-21 | Trial Unspecified | N | N | 210013740 | TRIAL |
| 210037749 | 210007657 | 1.68 | null | Curative (C) | null | 2018-12-21 | Trial Unspecified | Y | N | 210013754 | TRIAL |
| 210037750 | 210007669 | 1.76 | 85.9 | Curative (C) | 2014-01-02 | 2014-02-02 | Temozolomide + RT | N | N | 210013789 | TEMOZOLOMIDE + RT |
| 210037751 | 210007704 | 1.89 | 91.8 | Curative (C) | 2018-01-14 | 2018-02-18 | Temozolomide + RT | 2 | N | 210013874 | TEMOZOLOMIDE + RT |
| 210037752 | 210019118 | 1.73 | 77 | Palliative (P) | 2014-07-30 | 2014-09-14 | Temozolomide + RT | N | N | 210013914 | TEMOZOLOMIDE + RT |
| 210037753 | 210007748 | null | 65.4 | Palliative (P) | 2016-01-29 | 2016-02-16 | Temozolomide + RT | N | null | 210013944 | TEMOZOLOMIDE + RT |
| 210037755 | 210019129 | 1.59 | 87.6 | Curative (C) | 2016-08-28 | 2016-09-04 | Trial Unspecified | Y | N | 210013990 | TRIAL |
| 210037756 | 210007790 | 1.74 | 58.7 | Curative (C) | 2018-08-03 | 2018-08-31 | Temozolomide + RT | N | null | 210014046 | TEMOZOLOMIDE + RT |
| 210037757 | 210007810 | 1.69 | 62 | Disease modification (D) | 2016-08-11 | 2016-08-11 | Trial Unspecified | Y | Y | 210014068 | TRIAL |
| 210037758 | 210030538 | 1.8 | 65 | Curative (C) | 2015-02-28 | 2015-03-21 | Temozolomide + RT | N | N | 210014072 | TEMOZOLOMIDE + RT |
| 210037759 | 210007843 | 1.6 | 75.6 | Not known (9) | 2018-03-09 | 2018-03-17 | Rituximab | N | N | 210014139 | RITUXIMAB |
| 210037760 | 210007859 | null | 69 | Disease modification (D) | 2014-08-27 | 2014-09-17 | Lomustine | N | N | 210014168 | LOMUSTINE |
| 210037761 | 210007880 | null | 81.6 | Disease modification (D) | 2018-01-23 | 2018-09-23 | Rituximab | N | N | 210014253 | RITUXIMAB |
| 210037762 | 210007893 | 1.64 | 87.9 | Palliative (P) | 2018-08-04 | 2018-08-04 | Lomustine | N | Y | 210014273 | LOMUSTINE |
| 210037763 | 210007901 | 1.5 | 87.6 | Palliative (P) | 2015-08-04 | 2015-08-08 | Lomustine | N | N | 210014286 | LOMUSTINE |
| 210037764 | 210007908 | null | 134.2 | Palliative (P) | 2016-07-26 | 2017-05-01 | Lomustine | N | N | 210014295 | LOMUSTINE |
| 210037765 | 210007916 | null | null | Disease modification (D) | 2014-01-05 | 2014-12-15 | Rituximab | N | N | 210014311 | RITUXIMAB |
| 210037766 | 210007929 | 1.57 | 70.7 | Disease modification (D) | 2018-03-23 | 2018-09-26 | IBRUTINIB | N | N | 210014320 | IBRUTINIB |
| 210037767 | 210007980 | 1.58 | 58 | Palliative (P) | 2015-08-28 | 2016-01-15 | IBRUTINIB | 2 | N | 210014466 | IBRUTINIB |
| 210037768 | 210007991 | 1.69 | 61.4 | Curative (C) | 2014-01-14 | 2014-01-15 | IBRUTINIB | Y | N | 210014481 | IBRUTINIB |
| 210037769 | 210008001 | 1.85 | null | Curative (C) | 2018-06-02 | 2018-06-02 | Rituximab | N | N | 210014497 | RITUXIMAB |
| 210037770 | 210008022 | 1.59 | 72.4 | Curative (C) | 2016-01-13 | 2016-07-31 | FCR | Y | N | 210014510 | FCR |
| 210037771 | 210008033 | 1.65 | 67.8 | Curative (C) | 2015-11-16 | 2016-05-16 | Bendamustine+Rituximab(Sub Courses) | N | N | 210014519 | BENDAMUSTINE + RITUXIMAB |
| 210037772 | 210019219 | 1.67 | 72.3 | Disease modification (D) | 2019-01-06 | 2019-08-25 | FLAIR Trial | 1 | N | 210014561 | FLAIR TRIAL |
| 210037773 | 210008051 | null | null | Curative (C) | 2016-01-05 | 2016-01-13 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | Y | null | 210014576 | FCR |
| 210037774 | 210008062 | 1.82 | 92.6 | Curative (C) | 2016-02-24 | 2016-03-11 | FLAIR Trial | null | N | 210014595 | FLAIR TRIAL |
| 210037777 | 210019244 | 1.82 | 0 | Adjuvant (A) | 2019-02-26 | 2019-03-24 | Vincristine (weekly) | 2 | N | 210014674 | VINCRISTINE |
| 210037778 | 210008136 | 1.68 | 71.7 | Curative (C) | 2014-12-30 | 2014-12-30 | FCR Oral - Cycle 2 onwards | Y | N | 210014747 | FCR |
| 210037779 | 210008154 | null | 81.8 | Palliative (P) | 2018-03-28 | 2018-04-25 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 02 | null | 210014775 | FCR |